Medical Devices

Sysmex America's new XR-Series hematology analyzer promises to transform clinical labs with faster results, deeper insights, and a seamless workflow upgrade.

Meet the Austin trio behind Alafair Biosciences, whose innovative hydrogel technology is transforming surgical recovery and earning them top entrepreneurial honors.

A new partnership aims to deploy AI-powered imaging and advanced training across Asia Pacific, tackling the region's leading cause of death head-on.

A new manufacturing deal positions ViCentra to serve thousands more diabetes patients in Europe and sets the stage for a future U.S. market challenge.

A Tulsa jury found a doctor negligent, awarding $15M to a girl left with severe brain damage after a missed diagnosis of bacterial meningitis as an infant.

The cold storage giant's strategic acquisition of a pharma-certified specialist signals a major shift into the high-stakes world of medical logistics.

New preclinical data shows RTY-406 could be a first-in-class therapy for PSC, a progressive liver disease with no effective treatments.

Vanda Pharmaceuticals' rare disease drug gets a key designation in Japan, unlocking major incentives and promising a new treatment for a severe skin disease.

Former Samsung smartphone chief Blake Gaiser joins Eyesafe, signaling a major push to embed vision wellness tech into every device you own.

Ionetix wins FDA approval for its generic prostate cancer imaging agent, a move set to boost access and shake up the competitive radiopharmaceutical market.

Following its X3D acquisition, Catalyst MedTech unveils an expanded portfolio and a new strategy to tackle aging equipment and modernize nuclear medicine.

A Chinese firm services ultrasound machines in 140+ countries, challenging OEM dominance and helping hospitals cut costs and extend equipment life.

MBX Biosciences prepares for the Jefferies conference, with investors eyeing updates on its late-stage hypoparathyroidism drug and promising obesity portfolio.

A skincare brand is challenging the FDA over sunscreen ingredients, revealing decades of regulatory delay and raising questions about what’s safe for our skin.

With strong clinical data for its Dayspring system, Koya Medical is pitching to investors to fund the next phase of growth for its patient-centered tech.

By partnering with BioBrasil to produce key diagnostic probes locally, Aliko Scientific is not just entering a market; it's rewriting the rules of play.

French biotech TreeFrog Therapeutics isn't just replacing cells; it's implanting pre-wired networks. Their novel 3D microtissue shows faster, more extensive brain repair.

With child drownings on the rise, new federal funds aim to help local governments bolster pool safety, enforce laws, and prevent these tragic deaths.

Gene Solutions' AI-driven multi-omics liquid biopsy platform makes waves at a major oncology conference, finding a ready market in Taiwan.

Teva's new once-monthly olanzapine injection could revolutionize schizophrenia care in Europe, offering hope for better treatment adherence and patient outcomes.